Tylenol PM

Quick links to important sections

Tylenol PM

Method of action: Analgesic

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tylenol PM

The preparation is categorized as a fixed-dose combination drug for oral administration, designed to deliver the effects of a pain reliever and a sleep aid simultaneously. As a systemic medicine, this product contains two distinct synthetic compounds absorbed into the bloodstream to produce a dual therapeutic action.

Property Description
Active Ingredients Acetaminophen, Diphenhydramine hydrochloride
Form Tablet, Caplet, or Capsule
Pharmacological Class Analgesic / Antipyretic and First-Generation Antihistamine
General Purpose Pain relief with a sleep aid component
Origin Synthetic compounds

What Type of Medicine is Tylenol PM?

Tylenol PM is classified as a combination of an analgesic and antipyretic (Acetaminophen) with a first-generation antihistamine (Diphenhydramine), providing a dual-action profile distinct from single-agent medications. Acetaminophen belongs to the class of medications known as analgesics and antipyretics. This classification confirms that one component is intended to ease discomfort and reduce fever. The combination is clinically recognized for the concurrent management of mild to moderate pain and related sleep disturbance. These active components are typically formulated into solid dosage forms such as a tablet, caplet, or capsule, utilizing standard pharmaceutical excipients as the base/vehicle. This preparation is widely available as an over-the-counter (OTC) medication intended primarily for the adult target audience.


What are the Active Ingredients in Tylenol PM?

The two active ingredients are Acetaminophen (Paracetamol) and Diphenhydramine hydrochloride. Acetaminophen is included to modulate pain signals and reduce fever, which is crucial for managing discomfort. Diphenhydramine is primarily associated with sedation due to its antihistaminic effects within the central nervous system (CNS). This highlights that the second ingredient is responsible for promoting drowsiness and aiding rest. This specific formulation is one of several popular brands, with many analogous OTC preparations existing, offering the same dual-component mechanism of action.


What is the General Purpose of This Combination?

The general purpose of this combination drug is to address two concurrent issues: the experience of mild to moderate pain and the resultant occasional sleeplessness. A typical use scenario involves relief from minor aches, such as headache or muscle soreness, when that discomfort hinders the ability to fall asleep. The dual-action formulation enables the medication to achieve effective analgesia while simultaneously providing the sedation needed to counteract the wakefulness frequently associated with nighttime pain. This design is meant to offer integrated multi-symptom relief to users when discomfort hinders the ability to fall asleep or remain resting.

Regulatory References

  1. National Library of Medicine
  2. National Institutes of Health (NIH)

What side effects are possible with Tylenol PM?

Possible Side Effects and Safety Information

The safety profile of this medicine is derived from its two active components, Acetaminophen (analgesic) and Diphenhydramine (first-generation antihistamine), and is defined by officially documented adverse reactions and stringent regulatory safety constraints.


Official Adverse Reactions and Systemic Effects

The most frequent adverse events are associated with the antihistamine component. Drowsiness is an expected consequence of its use. Other effects documented in regulatory labeling primarily reflect anticholinergic activity and may involve the:

  • Nervous System: Dizziness or unsteadiness.
  • Gastrointestinal System: Dry mouth, dry nose, dry throat, and constipation.
  • Eye and Urinary Systems: Blurred vision, dry eyes, and difficulty in urination.

Serious Adverse Reactions and Key Regulatory Safety Warnings

Official government sources highlight rare but serious risks, primarily stemming from the acetaminophen component:

Serious Adverse Reaction Associated Component
Severe Liver Damage Acetaminophen
Severe Skin Reactions (SJS, TEN, AGEP) Acetaminophen

Severe liver damage is the highest safety priority, occurring most often when the maximum recommended daily dose is exceeded or when the medicine is consumed with three or more alcoholic drinks every day. Severe skin reactions are classified as rare but potentially fatal risks associated with the drug's use.

Population-Specific and Co-Use Constraints

Regulatory documentation restricts use in certain individuals and situations. Safety notes specify heightened risk for patients with pre-existing conditions such as Glaucoma, Liver Disease, or Trouble Urinating due to an enlarged prostate gland. The official labeling mandates that the product must not be used concurrently with any other product containing either acetaminophen or diphenhydramine to prevent accidental overdose and toxicity.

Overdose and Emergency Response

Documented Overdose Manifestations

Official regulatory documents define the overdose profile by the compound risks of its two active ingredients. The Acetaminophen component carries the risk of severe, delayed hepatotoxicity, potentially leading to acute liver failure and death. Initial presentation may be characterized by non-specific symptoms such as nausea, vomiting, and general malaise, which may not appear for some time after ingestion. In contrast, the Diphenhydramine component is associated with acute central nervous system (CNS) effects, including confusion, agitation, and severe outcomes such as seizures, respiratory depression, and coma. Cardiac arrhythmias are also documented risks, and paradoxical excitement is noted in pediatric patients.

When to Seek Urgent Help

Regulators mandate that immediate medical attention or contacting a Poison Control Center is required right away, even if no initial symptoms are present. This urgent action is necessary due to the potential for delayed, life-threatening liver damage. Urgent emergency services must be contacted for severe CNS manifestations such as seizures, loss of consciousness, or trouble breathing. The specific antidote, N-acetylcysteine (NAC), is officially indicated to treat Acetaminophen toxicity, necessitating serial serum acetaminophen levels and liver function tests for required hospital monitoring. For Diphenhydramine toxicity, official management is defined as symptomatic and supportive treatment, as no specific antidote is known. Patients with pre-existing liver disease are officially noted as being at a higher risk for severe hepatotoxicity.

Therapeutic Uses of Tylenol PM

What Tylenol PM Treats: Main Uses and Benefits

The product is applied across domains where additional symptomatic support is needed in situations involving certain distressing symptoms, namely minor physical discomfort and associated sleep interference. The product is commonly used when symptoms that interfere with daily functioning require **short-term symptomatic assistance.


Alleviating Discomfort and Assisting Rest

This preparation is relevant in contexts marked by increased discomfort or tension, and is commonly used to help with the dual symptom cluster of minor aches and pains alongside occasional sleeplessness. It helps address disruptive symptom manifestations such as headache, muscle soreness, backache, and minor joint pain that may become more disruptive during flare-ups. The dual action provides support that contributes to easing the overall symptom load during conditions characterized by periods of heightened symptoms.

“It is a relevant option when discomfort necessitates temporary assistance in stabilizing rest.”

This core use is relevant when physical discomfort prevents the ability to fall asleep or maintain a state of rest, covering pain-related nocturnal wakefulness. It supports the patient during difficult episodes and may assist with maintaining functional stability and helps improve day-to-day comfort during symptomatic periods.

Quick Fact: Supports relief for Minor Aches and Pain-Induced Sleeplessness

Regulatory References

  1. National Library of Medicine’s DailyMed label

Eligibility and Restrictions for Use

The eligibility for using Tylenol PM (Acetaminophen and Diphenhydramine) is strictly defined by official regulatory labeling, which establishes specific age requirements, pre-existing condition restrictions, and absolute contraindications.

Contraindicated Populations (Do Not Use)

Population Group/Activity Regulatory Basis
Children under 12 years of age Absolute age-based prohibition.
Severe Hepatic Impairment Absolute prohibition due to acetaminophen component.
Known Hypersensitivity Prior allergic reaction to any ingredient.
Concurrent use of other products Any other oral or topical product containing acetaminophen or diphenhydramine.

Conditional Use (Consultation Required)

Use is restricted, mandating consultation with a health professional before taking the medicine, for individuals with:

  • Liver Disease or consumption of three or more alcoholic drinks daily.
  • Glaucoma, breathing problems (e.g., emphysema), or difficulty urinating due to an enlarged prostate gland.
  • Pregnancy or Lactation Status.
  • Severe Renal Impairment.
  • Use is generally restricted in Older Adults and requires caution due to increased risk of side effects like dizziness and confusion.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for this combination product (Acetaminophen and Diphenhydramine hydrochloride) documents interactions across both active components.


Interactions Involving Acetaminophen

Co-administration with other medicines containing Acetaminophen is strictly prohibited, as regulatory agencies document a severe risk of cumulative hepatotoxicity and acute liver failure if the maximum daily dose is exceeded. Due to a reinforced risk of liver damage and enhanced central nervous system (CNS) depression, the regulatory label advises avoiding alcoholic drinks entirely during use. The label also notes that regular co-administration with the oral anticoagulant Warfarin may alter the International Normalized Ratio (INR), which measures bleeding risk. Furthermore, the risk of Acetaminophen-related toxicity is formally heightened for patients with pre-existing hepatic impairment.


Interactions Involving Diphenhydramine

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally contraindicated and requires a strict 14-day separation period before or after MAOI use, due to the potentiation of effects. An officially documented additive CNS depressant effect occurs when the product is used alongside other sedatives, tranquilizers, or opioid pain relievers, resulting in increased drowsiness. Finally, Diphenhydramine is documented as a known inhibitor of the CYP2D6 enzyme, a pharmacokinetic interaction that may lead to increased plasma exposure of certain co-administered drugs metabolized by this pathway.

Mechanism of Action

Central Arousal Pathway Suppression

This component primarily acts as an antagonist at central Histamine H1 receptors in the brain. By binding to these receptors, the drug blocks the transmission of histamine-mediated arousal signals. This action suppresses the CNS arousal system, resulting in central nervous system depression (somnolence).

Nociceptive Signal Modulation and Thermoregulation Reset

The analgesic component modulates nociceptive and thermoregulatory signaling via two simultaneous central mechanisms. It inhibits key Cyclooxygenase ( COX) enzymes within the CNS, which reduces the synthesis of prostaglandins ( PGE2) involved in modulating thermal signaling. Concurrently, it indirectly modulates the CB1 receptor pathway, affecting the brain's descending pain-inhibitory signals. This leads to reduction in nociceptive signal transmission and resets the hypothalamic temperature set point, initiating peripheral heat dissipation.

Functional Synergistic Mechanism

The two mechanisms exhibit functional complementarity. The modification of physiological signaling that contributes to nociception occurs alongside the suppression of arousal pathways. This combined modulation of both the nociception and alertness systems results in a co-occurring physiological state of diminished nociception and central nervous system depression.

Dosage and Administration Information

Official Administration Guidelines

The usage of this fixed-dose combination product, containing Acetaminophen (500 mg) and Diphenhydramine HCl (25 mg) per unit, is governed by the established instructions for the product. Adherence to these guidelines is necessary for proper administration.


Dosing and Schedule

Feature Instruction
Route of Administration Oral (swallowing the caplet, tablet, or gelcap form).
Standard Dosing Two units (e.g., 2 caplets) in a single dose.
Frequency and Timing Administered once daily and must be taken at bedtime.
Maximum Daily Dose Do not take more than two units (1000 mg Acetaminophen / 50 mg Diphenhydramine HCl) in any 24-hour period.

Procedural Constraints

Administration is authorized for adults and children 12 years and over. The product is not for use in children under 12 years of age. A primary procedural constraint is the absolute prohibition on co-administration; the medicine must not be used with any other product containing either acetaminophen or diphenhydramine. The overall pattern of use is limited to the short-term management of occasional symptoms, as described in the product labeling.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tylenol PM


Evidence for Use in Occasional Sleeplessness Associated with Minor Aches and Pains

The research base for this medication includes short-term Randomized Controlled Trials (RCTs) and Systematic Reviews that have explored how symptoms change over time. These studies were applied in research contexts involving individuals who were experiencing temporary physical discomfort that made it difficult to fall asleep. The trials aimed to examine measures of physical discomfort (pain intensity) and measures related to sleep parameters.

Findings describe patterns observed in the studies related to changes in reported pain intensity, and research also explored changes measured during the study period for sleep onset latency (the time it took to fall asleep). However, evidence derived from settings with varying symptom burdens has resulted in mixed findings across authoritative reviews regarding the overall consistency of the measurements related to sleep.


Duration of Evidence: Short-Term Use and Follow-up

The available evidence is primarily relevant in trials assessing short-term or episodic symptom patterns. Research exploring short-term symptom changes has focused on the effects of a single dose or repeated doses over a limited timeframe. Typical observation periods in these trials range from a few nights up to approximately two to four weeks of consecutive use.

Follow-up durations were limited, and there is limited information for long-term outcomes or repeated, chronic use. The existing studies provide insight into short-term changes, but long-term effects are not fully established.


What Remains Unclear or Uncertain About the Evidence Base

The overall evidence contributes to understanding symptom patterns, but the certainty remains low in some areas of effect. Evidence quality varies across studies, and major systematic reviews have pointed out that the findings related to the sleep-aid component were inconsistent.

This inconsistency means that the combination of ingredients was associated with varied responses in different studies. Additionally, the research has not fully characterized the potential for residual effects, such as daytime drowsiness, and data are still emerging in this area.

Key Studies & References

  1. Tylenol PM (acetaminophen, diphenhydramine hydrochloride) label - DailyMed
  2. Acetaminophen: a critical review of the literature for its use in the management of pain

Frequently Asked Questions (FAQ)

Common questions about Tylenol PM (FAQ)


Q: How long does the sleep-aid part of Tylenol PM usually last?

Official information indicates the product is intended for a single nighttime use, administered at bedtime for the temporary relief of occasional sleeplessness. Regulatory documents advise consulting a health professional if sleeplessness continues for more than two weeks, reinforcing the purpose of short-term, temporary use.

Q: How quickly does the pain relief component of Tylenol PM start to work?

The pain-relieving ingredient is Acetaminophen, which is formulated for rapid action. Authoritative medical sources generally describe the onset of pain relief for this type of oral formulation as being within 30 minutes to one hour.

Q: Is it normal to feel groggy the morning after taking Tylenol PM?

Drowsiness is a commonly expected consequence of using this product, as noted in the warnings. The sleep-aid ingredient, Diphenhydramine, is associated with sedation which may sometimes persist. Official documentation lists drowsiness as a potential side effect which may sometimes persist.

Q: What is the mechanism by which the 'PM' ingredient promotes sleep?

The 'PM' ingredient, Diphenhydramine, is a first-generation antihistamine. It promotes drowsiness by acting on the central nervous system to block histamine receptors. This action suppresses the brain's natural arousal signals, leading to sedation and the intended sleep-aid effect.

Q: Why is Tylenol PM commonly used for pain and sleeplessness?

The medication is officially indicated for the temporary relief of minor aches and pains that are specifically accompanied by sleeplessness. Its combination of an analgesic (pain reliever) and a sleep aid is formulated to address both concurrent symptoms in a single dose.

Q: Is Tylenol PM classified as a nonsteroidal anti-inflammatory drug (NSAID)?

No. The pain reliever component, Acetaminophen, is classified as an analgesic and an antipyretic. Unlike NSAIDs, it is not generally categorized as an anti-inflammatory drug.

Q: What are the official warnings about potential stomach bleeding with Tylenol PM?

The key safety warnings for this product focus on the potential for severe liver damage and severe skin reactions (SJS, TEN, AGEP) related to the Acetaminophen component. Official labeling for this product does not list stomach bleeding as a specific warning.

Q: Is Tylenol PM considered a narcotic or controlled substance?

No. The product is classified as an Over-the-Counter (OTC) medicine. Its active ingredients, Acetaminophen and Diphenhydramine, are not listed as controlled substances.

Q: Can Tylenol PM be used if I only have pain but no trouble sleeping?

The official product label specifies its use for pain with accompanying sleeplessness and mandates that the medicine be taken at bedtime. Official product information indicates it is not intended for pain relief alone.

Q: Are there any research studies on the effectiveness of Tylenol PM?

The research base includes short-term Randomized Controlled Trials (RCTs) that have examined changes in reported pain intensity and changes in sleep parameters, such as the time it takes to fall asleep. However, reviews have indicated that the consistency of the evidence related to the sleep-aid component has varied across studies.

Q: Can Tylenol PM cause dependence if used frequently?

Official guidelines limit the overall pattern of use to the short-term management of occasional symptoms. This aligns with the product's limited period of use and its intended purpose for occasional symptoms.

Q: Is there a maximum number of nights Tylenol PM should be used in a row?

Official labeling advises consumers to stop use and ask a doctor if sleeplessness persists continuously for more than two weeks. For pain symptoms, the instruction is to stop use if pain lasts more than 10 days.

Q: Can Tylenol PM be taken if I am already taking blood pressure medication?

Official information stresses the need for professional consultation when co-administering with any other prescription medicine, including drugs like the blood thinner Warfarin, sedatives, and tranquilizers.

Q: Are there any documented interactions between Tylenol PM and cold medicine?

The label contains a strict prohibition against using this product with any other medicine containing acetaminophen or diphenhydramine. Many cold and flu preparations contain one or both of these active ingredients, making concurrent use a contraindication due to the risk of accidental overdose.

Q: Can Tylenol PM affect the results of any medical tests?

Authoritative information on the Acetaminophen component notes that it may interfere with the results of some medical tests. This interference has been documented with certain laboratory tests, including those for blood glucose levels.

Q: Is it true that Tylenol PM is not for chronic insomnia?

Official labeling indicates the product is for the temporary relief of occasional sleeplessness. Consumers are advised to stop use if sleeplessness persists continuously for more than two weeks, as persistent symptoms may be a sign of a serious underlying medical condition.

Q: What should be done if too much Tylenol PM is taken?

The official warning advises consumers to get medical help or contact a Poison Control Center right away in case of an accidental overdose. Quick medical attention is considered critical, even if no immediate signs or symptoms are noticed.

Q: How does the sleep aid in Tylenol PM differ from melatonin?

The sleep aid in this product, Diphenhydramine, is a synthetic first-generation antihistamine that promotes sedation by blocking histamine receptors in the brain. Melatonin, in contrast, is a naturally occurring hormone whose mechanism involves regulating the body's sleep-wake cycle (circadian rhythm).

Q: What kind of research has been done on long-term, non-daily use of Tylenol PM?

The majority of the available evidence is relevant for trials assessing short-term or episodic symptom patterns over a limited timeframe. The long-term effects or the safety profile of repeated use beyond the short-term study period are not fully established in the existing literature.

Q: What are the possible signs of an allergic reaction to Tylenol PM ingredients?

The official label includes an Allergy Alert and warns of potential severe skin reactions. Symptoms of a severe reaction may include skin reddening, blisters, or a rash. Other signs noted in regulatory documentation can include hives or difficulty breathing.

Q: Is Tylenol PM known to cause feelings of confusion in some people?

Authoritative sources for the active sleep-aid component list mental or mood changes, such as confusion, as a possible serious adverse effect. This side effect has been noted with increased frequency in older adults.

Q: How should missed use of Tylenol PM be handled according to packaging instructions?

Since the product is intended for single-dose use at bedtime for occasional symptoms, the directions do not include specific guidance for a 'missed dose.' The product label instructs users to not take more than the recommended amount within any 24-hour period.

Q: Are there specific food interactions noted for Tylenol PM?

The primary interaction warning is the instruction to avoid alcoholic drinks. Otherwise, regulatory information generally indicates that if stomach upset occurs, the medication may be taken with food or milk.

Q: Why do some people report feeling restless instead of sleepy after taking Tylenol PM?

The active sleep-aid ingredient, Diphenhydramine, is associated with a rare reaction known as paradoxical excitation. This reaction can cause symptoms such as restlessness, agitation, or excitement instead of the intended drowsiness, particularly in certain age groups.

Q: What research exists about the use of Tylenol PM for tension headaches and sleep issues?

The research base covers studies involving temporary physical discomfort and minor aches and pains, which includes headaches, that interfere with the ability to fall asleep. The evidence examines the product's effects on both pain intensity and general sleep parameters.

Q: What is the current safety classification of Tylenol PM by major regulatory bodies?

The official labeling provides several safety classifications and restrictions. These include an absolute prohibition on use by children under 12 years of age and conditional use warnings requiring professional consultation for specific populations, such as those who are pregnant or breastfeeding.

How should Tylenol PM be stored and disposed of?

Storage and Disposal of Tylenol PM

Official regulatory guidelines strictly define the conditions necessary to maintain the integrity and safety of this product.


Storage Requirements

Tylenol PM must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be kept in a dry place and should avoid high humidity to preserve stability. It is a mandatory requirement that the medication be stored out of the reach of children.

Packaging and Handling

Do not use the product if the outer carton is open or if the inner protective seal is broken or missing. Maintaining the integrity of the original packaging is essential for protection.

Disposal

When the medication is expired or no longer needed, unused Tylenol PM must be discarded according to local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tylenol PM found in:

A-Z Index: